In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Bamboo Therapeutics closes $49.5mm Series A round; Pfizer takes equity stake

Executive Summary

Bamboo Therapeutics Inc. (gene therapies focused on orphan neurological diseases) completed a $49.5mm Series A round with participation from Pfizer Inc., CureDuchenne Ventures, and four other undisclosed investors. Pfizer contributed $43mm for a 22% equity stake in Bamboo.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register